Log in to your Inderes Free account to see all free content on this page.

Diamyd Medical

1.05 SEK

+3.33%

Less than 1K followers

DMYD B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Diamyd Medical

P/E

Median 2019-2025

EV/S

Median 2019-2022

EV/EBIT

Median 2019-2022

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)8.1138.4432.7514.179.7416.3411.30
Shares71.271.273.679.277.3100.2137.5
Market cap577.62,735.62,411.91,121.6753.11,637.51,553.7
Enterprise value521.62,668.02,273.31,002.6---
EV/S332.77,824.28,985.32,228.0---
EV/EBITDAneg.269.8neg.neg.---
EV/EBITneg.274.0neg.neg.---
P/Eneg.281.940.2neg.neg.neg.neg.
P/B9.2037.7412.745.234.0711.225.55
P/S368.38,022.49,533.12,492.41,369.312,595.811,951.9
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio84.6 %80.8 %94.0 %90.6 %90.0 %67.2 %79.4 %
Gearing ratio1.2 %1.1 %0.4 %0.4 %0.4 %--
Login required

This content is only available for logged in users